PGEN Precigen Inc Net earnings per share growth forecast for next year
Precigen, Inc. (PGEN) complies with environmental regulations for biohazardous waste disposal, and the EPS growth forecasting model for the coming year on GURU.Markets reflects the impact of this compliance. 157.40 shows the current value of the metric. Balance sheet stability is supported by flexible testing costs, while management aims to accelerate the market launch of gene therapies to achieve positive cash flow.
precigen.com - analytical breakdowns and key metrics (PGEN)
- stock quotes and analyst forecast:
- market capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
- earnings and valuation multiples information:
PGEN - Annual Net Income|Projected Future Earnings Precigen, Inc.|PGEN - Market Cap to Earnings|Future Price to Earnings Precigen, Inc.|PGEN - Growth-Adjusted P/E Ratio|Enterprise Value to EBITDA Ratio Precigen|PGEN - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Precigen|PGEN - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months precigen.com|PGEN - Earnings per share growth this year|Earnings growth forecast for next year Precigen, Inc.
- total revenue and sales volume data:
Fundamental company analysis:Intrexon, PGEN
Precigen, Inc. (PGEN) is striving for the commercialization of its gene platforms, meaning that the trend in earnings expectations for the coming year serves as an indicator of market confidence in the success of clinical trials and regulatory approval. By analyzing this daily price chart of the EPS N+1 consensus forecast on GURU.Markets, an investor can assess the pace of risk repricing and the stabilization of operational plans, where a steady growth trajectory confirms the long-term potential for monetizing innovations.
Analysis of competing companies
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year BioNTech Pharma|Net earnings per share growth forecast for next year Abivax (ABVX)|admabiologics.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (Protagonist)|Immunovant Inc (IMVT) - Expected net earnings per share growth next year|KNSA - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year GRFS|Adaptive Biotechnologies (ADPT) - Net earnings per share growth forecast for next year|celldex.com - Expected earnings per share trend next year|AUPH (Aurinia Pharmaceuticals Inc.) - Earnings growth forecast for next year|Expected net earnings per share growth next year BioCryst Pharmaceuticals, Inc. BCRX|Earnings growth forecast for next year VERA|Expected earnings per share growth for next year Dianthus Corp DNTH|Earnings growth forecast for next year PHVS (Pharvaris N.V.)|Consensus forecast of earnings per share growth for next year abcellera.com (ABCL)|Tourmaline Bio - Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Pharming Group NV (PHAR)|NKTR: Earnings growth forecast for next year|Expected net earnings per share growth next year Upstream Pharma (UPB)|Net earnings per share growth forecast for next year Zenas Biopharma Inc|Projected earnings per share growth rate for next year IMNM (immunome.com)|Expected earnings per share growth for next year GOSS (Gossamer Bio)|KALV (KalVista Pharma) - Expected earnings per share trend next year|Earnings growth forecast for next year SEPN (Septerna Corp)|Consensus forecast of earnings per share growth for next year Pieris Corp (PVLA)|SVRA - Net earnings per share growth forecast for next year|RIGL (rigel.com) - Projected earnings per share growth rate for next year|ANAB: Earnings growth forecast for next year|Expected earnings per share growth for next year Astria Therapeutics Inc|Expected earnings per share growth for next year ENGN|RAPT Therapeutics Inc. (RAPT) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Aerovate Therapeutics Inc (JBIO)|ACRS: Net earnings per share change forecast for next year|Earnings growth forecast for next year KYTX (Kyverna Therapeutics, Inc.)|Net earnings per one share growth forecast for next year Tiziana Life Sciences Ltd.|Cabaletta Bio, Inc - Earnings growth forecast for next year|Expected net earnings per share growth next year Ventyx Biosciences, Inc|Theratechnologies Inc. (THTX) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year AVTX|Net earnings per share growth forecast for next year Eledon Pharmaceuticals, Inc.|Agenus, Inc. - Net earnings per share change forecast for next year|Earnings growth forecast for next year CLYM|ZURA (Zura Bio Ltd) - Expected earnings per share trend next year|Earnings growth forecast for next year ATYR (aTyr Pharma, Inc.)|Earnings growth forecast for next year Adagene Inc ADAG|IMA - Net earnings per share growth forecast for next year|Expected earnings per share trend next year STTK (Shattuck Labs, Inc.)|equilliumbio.com (EQ) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Connect Biopharma Holdings Limited|IMUX (Immunic Therapeutics) - Earnings growth forecast for next year|Earnings growth forecast for next year Atara Biotherapeutics Inc|Expected earnings per share growth for next year IFRX (InflaRx N.V.)|XFOR (X4 Pharmaceuticals Inc.) - Expected earnings per share trend next year|Earnings growth forecast for next year ACET (Adicet Bio, Inc.)|Consensus forecast of earnings per share growth for next year Celularity Inc (CELU)|INMB - Net earnings per share growth forecast for next year|barinthusbio.com (BRNS) - Expected earnings per share growth for next year|Kezar Life Sciences, Inc. (KZR) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year SAB Biotherapeutics Inc.|Expected earnings per share growth for next year AKTX|Earnings growth forecast for next year Enlivex Therapeutics, Ltd.|Net earnings per share growth forecast for next year Q32 Bio Inc. (QTTB)|geovax.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year EDSA (Edesa Biotech)|iBio Inc (IBIO) - Expected net earnings per share growth next year|CARM - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year XTLB|boltbio.com (BOLT) - Net earnings per share growth forecast for next year|HCW Biologics - Expected earnings per share trend next year|APVO (Aptevo Therapeutics, Inc.) - Earnings growth forecast for next year|Expected net earnings per share growth next year AIM ImmunoTech, Inc. AIM|Earnings growth forecast for next year ADTX|Expected earnings per share growth for next year GRI Bio Corporation GRI|Earnings growth forecast for next year XRTX (XORTX Therapeutics Inc.)|Consensus forecast of earnings per share growth for next year reshapelifesciences.com (HIND)|Revelation Biosciences, Inc. - Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Indaptus Therapeutics Inc (INDP)|SCNI: Earnings growth forecast for next year|Expected net earnings per share growth next year CalciMedica (CALI)|Net earnings per share growth forecast for next year Affimed NV|Projected earnings per share growth rate for next year ALLK (Allakos Therapeutics)|Expected earnings per share growth for next year HOOK (HOOKIPA Pharma Inc.)|IGMS (igmbio.com) - Expected earnings per share trend next year|Earnings growth forecast for next year ITOS (iTeos)|Consensus forecast of earnings per share growth for next year Ocean Biomedical Corp (OCEA)|TCBP - Net earnings per share growth forecast for next year|THRD (thirdharmonicbio.com) - Projected earnings per share growth rate for next year
